Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Neuschwander-Tetri, 2003, Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference, HEPATOLOGY, 37, 1202, 10.1053/jhep.2003.50193
Matteoni, 1999, Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity, Gastroenterology, 116, 1413, 10.1016/S0016-5085(99)70506-8
McCullough, 2006, Thiazolidinediones for nonalcoholic steatohepatitis: promising but not ready for prime time, N Engl J Med, 355, 2361, 10.1056/NEJMe068232
Torres, 2008, Diagnosis and therapy of nonalcoholic steatohepatitis, Gastroenterology, 134, 1682, 10.1053/j.gastro.2008.02.077
Neuschwander-Tetri, 2003, Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone, HEPATOLOGY, 38, 1008, 10.1053/jhep.2003.50420
Promrat, 2004, A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis, HEPATOLOGY, 39, 188, 10.1002/hep.20012
Belfort, 2006, A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis, N Engl J Med, 355, 2297, 10.1056/NEJMoa060326
Lutchman, 2007, The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis, HEPATOLOGY, 46, 424, 10.1002/hep.21661
Marchesini, 2001, Nonalcoholic fatty liver disease: a feature of the metabolic syndrome, Diabetes, 50, 1844, 10.2337/diabetes.50.8.1844
Sanyal, 2002, AGA technical review on nonalcoholic fatty liver disease, Gastroenterology, 123, 1705, 10.1053/gast.2002.36572
Wang, 2003, Is weight reduction an effective therapy for nonalcoholic fatty liver? A systematic review, Am J Med, 115, 554, 10.1016/S0002-9343(03)00449-2
Clark, 2006, Weight loss as a treatment for nonalcoholic fatty liver disease, J Clin Gastroenterol, 40, S39
Wing, 1998, Behavioral approaches to the treatment of obesity, 855
2002, The Diabetes Prevention Program (DPP): description of lifestyle intervention, Diabetes Care, 25, 2165, 10.2337/diacare.25.12.2165
Knowler, 2002, Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin, N Engl J Med, 346, 393, 10.1056/NEJMoa012512
Pi-Sunyer, 2007, Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial, Diabetes Care, 30, 1374, 10.2337/dc07-0048
Ryan, 2003, Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes, Control Clin Trials, 24, 610, 10.1016/S0197-2456(03)00064-3
Kleiner, 2005, Design and validation of a histological scoring system for nonalcoholic fatty liver disease, HEPATOLOGY, 41, 1313, 10.1002/hep.20701
Flechtner-Mors, 2000, Metabolic and weight loss effects of long-term dietary intervention in obese patients: four-year results, Obes Res, 8, 399, 10.1038/oby.2000.48
Jeffery, 1995, Long-term effects of interventions for weight loss using food provision and monetary incentives, J Consult Clin Psychol, 63, 793, 10.1037/0022-006X.63.5.793
Wadden, 1997, Exercise in the treatment of obesity: effects of four interventions on body composition, resting energy expenditure, appetite, and mood, J Consult Clin Psychol, 65, 269, 10.1037/0022-006X.65.2.269
Wing, 1996, Food provision vs structured meal plans in the behavioral treatment of obesity, Int J Obes Relat Metab Disord, 20, 56
Ditschuneit, 1999, Metabolic and weight-loss effects of a long-term dietary intervention in obese patients, Am J Clin Nutr, 69, 198, 10.1093/ajcn/69.2.198
FX, 1992, The Effects of Increased Physical Activity on Food Intake, Metabolic Rate, and Health Risks in Obese Individuals, 190
Jakicic, 1999, Effects of intermittent exercise and use of home exercise equipment on adherence, weight loss, and fitness in overweight women: a randomized trial, JAMA, 282, 1554, 10.1001/jama.282.16.1554
D'Zurilla, 1971, Problem solving and behavior modification, J Abnorm Psychol, 78, 107, 10.1037/h0031360
Marlatt, 1985, Relapse Prevention: Maintenance Strategies in Addictive Behavior Change
Grundy, 2005, Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement, Circulation, 112, 2735, 10.1161/CIRCULATIONAHA.105.169404
Bellentani, 2008, Behavior therapy for nonalcoholic fatty liver disease: the need for a multidisciplinary approach, HEPATOLOGY, 47, 746, 10.1002/hep.22009
Huang, 2005, One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study, Am J Gastroenterol, 100, 1072, 10.1111/j.1572-0241.2005.41334.x
Hickman, 2004, Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life, Gut, 53, 413, 10.1136/gut.2003.027581
Thomas, 2006, Effect of nutritional counselling on hepatic, muscle and adipose tissue fat content and distribution in non-alcoholic fatty liver disease, World J Gastroenterol, 12, 5813, 10.3748/wjg.v12.i36.5813
Suzuki, 2005, Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease, J Hepatol, 43, 1060, 10.1016/j.jhep.2005.06.008
Kugelmas, 2003, Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E, HEPATOLOGY, 38, 413, 10.1053/jhep.2003.50316
Sreenivasa Baba, 2006, Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis, J Gastroenterol Hepatol, 21, 191, 10.1111/j.1440-1746.2005.04233.x
Petersen, 2005, Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes, Diabetes, 54, 603, 10.2337/diabetes.54.3.603
Drenick, 1970, Effect on hepatic morphology of treatment of obesity by fasting, reducing diets and small-bowel bypass, N Engl J Med, 282, 829, 10.1056/NEJM197004092821502
Palmer, 1990, Effect of weight reduction on hepatic abnormalities in overweight patients, Gastroenterology, 99, 1408, 10.1016/0016-5085(90)91169-7
Aithal, 2008, Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis, Gastroenterology, 135, 1176, 10.1053/j.gastro.2008.06.047